Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.

Puskás László and Mán Imola and Szebeni Gábor and Tiszlavicz László and Tsai Susan and James Michael A.: Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
MOLECULAR CANCER THERAPEUTICS, 15 (5). pp. 985-997. ISSN 1535-7163 (2016)

[thumbnail of MCT_Tiszlavicz_2016_u.pdf] Text
MCT_Tiszlavicz_2016_u.pdf - Published Version
Restricted access: Registered users only

Download (3MB) | Request a copy
Item Type: Journal Article
Journal or Publication Title: MOLECULAR CANCER THERAPEUTICS
Date: 2016
Volume: 15
Number: 5
Page Range: pp. 985-997
ISSN: 1535-7163
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3032869
DOI azonosító: https://doi.org/10.1158/1535-7163.MCT-15-0717
Date Deposited: 2017. Jul. 27. 14:37
Last Modified: 2019. Dec. 05. 16:32
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11815
Web of Science® Times Cited: 10 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year